Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Joanne McEntee"'
Autor:
Nigel Fleeman, Rachel Houten, Sarah Nevitt, James Mahon, Sophie Beale, Angela Boland, Janette Greenhalgh, Katherine Edwards, Michelle Maden, Devarshi Bhattacharyya, Marty Chaplin, Joanne McEntee, Shien Chow, Tom Waddell
Publikováno v:
Health Technology Assessment, Vol 28, Iss 49 (2024)
Background Renal cell carcinoma is the most common type of kidney cancer, comprising approximately 85% of all renal malignancies. Patients with advanced renal cell carcinoma are the focus of this National Institute for Health and Care Excellence mult
Externí odkaz:
https://doaj.org/article/138a4e51d8f84239b6712ba1b3c2f5c3
Autor:
Janette Greenhalgh, Adrian Bagust, Angela Boland, Kerry Dwan, Sophie Beale, Nigel Fleeman, Joanne McEntee, Yenal Dundar, Marty Richardson, Michael Fisher
Publikováno v:
Health Technology Assessment, Vol 19, Iss 29 (2015)
Background: Acute coronary syndromes (ACSs) are life-threatening conditions associated with acute myocardial ischaemia. There are three main types of ACS: ST segment elevation myocardial infarction (STEMI), non-ST segment elevation myocardial infarct
Externí odkaz:
https://doaj.org/article/64268a50cc8d45b4acb63daf83f41361
Autor:
Rebecca Bresnahan, Rachel Houten, Janette Greenhalgh, Sarah Nevitt, James Mahon, Sophie Beale, Angela Boland, Devarshi Bhattacharyya, Yenal Dundar, Joanne McEntee, Shreyans Gandhi, Nigel Fleeman, Marty Chaplin
Publikováno v:
PharmacoEconomics - Open.
As part of the Single Technology Appraisal (STA) process, the UK National Institute for Health and Care Excellence (NICE) invited Apellis Pharmaceuticals/Sobi to submit evidence for the clinical and cost effectiveness of pegcetacoplan versus eculizum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6c6c890e99706f686c61ba45cdf9234b
https://doi.org/10.1007/s41669-023-00408-z
https://doi.org/10.1007/s41669-023-00408-z
Autor:
Danny Palnoch, John Spoors, Joanne McEntee, Sheena Vithlani, John Cairns, Ash Summerfield, Alec Miners
Publikováno v:
BioDrugs. 35:1-5
Advanced therapy medicinal products (ATMPs) are a dynamic and current topic for healthcare systems, with new products progressing to market at an increasing rate. ATMPs highlight the growing gap between payer and regulator requirements; the limited e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c28ccb7c38798a0a2fc89431b1570ddf
https://doi.org/10.1007/s40259-020-00457-4
https://doi.org/10.1007/s40259-020-00457-4
Autor:
Sophie Beale, Marty Chaplin, Joanne McEntee, Rachel Houten, Yenal Dundar, Isabel Syndikus, Nigel Fleeman, Angela Stainthorpe, Angela Boland
Publikováno v:
PharmacoEconomics Open
PharmacoEconomics-open
PharmacoEconomics-open
As part of the single technology appraisal process, the National Institute for Health and Care Excellence invited Takeda UK Ltd to submit clinical- and cost-effectiveness evidence for brentuximab vedotin (BV) for treating relapsed or refractory CD30-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b578053920f47c4c993a780597261b2
http://europepmc.org/articles/PMC7688836
http://europepmc.org/articles/PMC7688836
Autor:
Yenal Dundar, Sajjad Ahmad, Sarah J Nevitt, Nigel Fleeman, Joanne McEntee, Angela Boland, James Mahon, Rui V. Duarte, Eleanor Kotas
Publikováno v:
PharmacoEconomics Open
As part of the Single Technology Appraisal (STA) process, the National Institute for Health and Care Excellence (NICE) invited the manufacturer of cenegermin (OXERVATE®, Dompe) to submit evidence for the clinical and cost effectiveness of cenegermin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8593e460210704de7bb9a4dfefb36637
http://europepmc.org/articles/PMC6861391
http://europepmc.org/articles/PMC6861391
Autor:
John, Spoors, Alec, Miners, John, Cairns, Danny, Palnoch, Ash, Summerfield, Joanne, McEntee, Sheena, Vithlani
Publikováno v:
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy. 35(1)
Advanced therapy medicinal products (ATMPs) are a dynamic and current topic for healthcare systems, with new products progressing to market at an increasing rate. ATMPs highlight the growing gap between payer and regulator requirements; the limited e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1ebd1b32d46f85e145428b6e83b131db
https://pubmed.ncbi.nlm.nih.gov/33226582
https://pubmed.ncbi.nlm.nih.gov/33226582
Autor:
Tosin Lambe, Angela Boland, James Mahon, Janette Greenhalgh, Eleanor Kotas, Sarah J Nevitt, Yenal Dundar, Sophie Beale, Joanne McEntee, Rachel Houten
Publikováno v:
PharmacoEconomics Open
As part of the Single Technology Appraisal process, the National Institute for Health and Care Excellence (NICE) invited Pierre Fabre to submit evidence for the clinical and cost-effectiveness of encorafenib with binimetinib (Enco + Bini) versus dabr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74bcddaaaedad6a0f083f84dba6941ef
https://pubmed.ncbi.nlm.nih.gov/32291725
https://pubmed.ncbi.nlm.nih.gov/32291725
Autor:
Joanne McEntee, Eleanor Kotas, Ahmed Abdulla, Daniel H. Palmer, Marty Richardson, Nigel Fleeman, Angela Boland, Angela Stainthorpe, Sophie Beale, Adrian Bagust
Publikováno v:
PHARMACOECONOMICS
BASE-Bielefeld Academic Search Engine
BASE-Bielefeld Academic Search Engine
The National Institute for Health and Care Excellence (NICE) invited the manufacturer (Shire Pharmaceuticals) of pegylated liposomal irinotecan hydrochloride trihydrate (liposomal irinotecan) to submit clinical and cost-effectiveness evidence for its
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1cb372e7fd978e391a668b57cd9c20ed
http://livrepository.liverpool.ac.uk/3013556/1/nal-iri_PE_manuscript_re-submitted_clean.docx
http://livrepository.liverpool.ac.uk/3013556/1/nal-iri_PE_manuscript_re-submitted_clean.docx
Autor:
Joanne McEntee
Publikováno v:
Irish Historical Studies. 39:538-540
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a8b0002b5769a7ea6a212973664bb8a3
https://doi.org/10.1017/ihs.2015.9
https://doi.org/10.1017/ihs.2015.9